open access

Vol 85, No 4 (2017)
ORIGINAL PAPERS
Published online: 2017-08-28
Submitted: 2017-06-20
Accepted: 2017-08-24
Get Citation

Selected aspects of medical care for patients with asthma and chronic obstructive pulmonary disease (COPD) in Poland

Joanna Miłkowska-Dymanowska, Adam J. Białas, Paweł Górski
DOI: 10.5603/ARM.2017.0030
·
Adv Respir Med 2017;85(4):179-185.

open access

Vol 85, No 4 (2017)
ORIGINAL PAPERS
Published online: 2017-08-28
Submitted: 2017-06-20
Accepted: 2017-08-24

Abstract

INTRODUCTION: Noncompliance with healthcare undoubtedly has a strong influence on the high prevalence of uncontrolled obstructive diseases. The aim of our study was to evaluate the quality of medical conduct in patients with asthma or chronic obstructive lung diseases (COPD), with encompassed two-levelled system of health care.

MATERIAL AND METHODS: A survey of general practitioners (GP), allergists and pulmonologists practicing in Poland was performed between September and December 2016. The basic survey included the data concerning the number of treated patients, the course of the visits, treatment regimens and whether the patients follow the instructions of the physician. The specialist survey recorded the details of the specialist visits, their frequency and character, an evaluation of the pharmacological and non-pharmacological therapies and an evaluation of the GP’s actions.

RESULTS: The basic questionnaire was completed by 807 doctors with an average of 21 ± 9.85 years of medical experience. Most of the interviewed individuals were GPs (56%), followed by pulmonologists (28%) and allergists (16%). The GP reported 47 cases/month with obstructive pulmonary conditions, including 48.94% asthma and 51.06% COPD patients. They diagnosed three new asthma and COPD patients per month. The allergists treated patients with asthma (105 patients/ month), with 19 newly-diagnosed patients/month. The pulmonologists treated fewer asthma cases than COPD: 71 and 98 patients respectively. They reported 14 patients/month of newly-diagnosed COPD cases. The patients took inhaled glucocorticoids and long-acting b adrenoceptor agonists in separate inhalers. The most frequently-used device was a disc. In opinion of the specialists, half of the therapies initiated recently by GPs for patients with asthma and COPD required modifications.

CONCLUSIONS: There is a disparity between the true state of medical care of asthma and COPD patients and globally-accepted standards.

Abstract

INTRODUCTION: Noncompliance with healthcare undoubtedly has a strong influence on the high prevalence of uncontrolled obstructive diseases. The aim of our study was to evaluate the quality of medical conduct in patients with asthma or chronic obstructive lung diseases (COPD), with encompassed two-levelled system of health care.

MATERIAL AND METHODS: A survey of general practitioners (GP), allergists and pulmonologists practicing in Poland was performed between September and December 2016. The basic survey included the data concerning the number of treated patients, the course of the visits, treatment regimens and whether the patients follow the instructions of the physician. The specialist survey recorded the details of the specialist visits, their frequency and character, an evaluation of the pharmacological and non-pharmacological therapies and an evaluation of the GP’s actions.

RESULTS: The basic questionnaire was completed by 807 doctors with an average of 21 ± 9.85 years of medical experience. Most of the interviewed individuals were GPs (56%), followed by pulmonologists (28%) and allergists (16%). The GP reported 47 cases/month with obstructive pulmonary conditions, including 48.94% asthma and 51.06% COPD patients. They diagnosed three new asthma and COPD patients per month. The allergists treated patients with asthma (105 patients/ month), with 19 newly-diagnosed patients/month. The pulmonologists treated fewer asthma cases than COPD: 71 and 98 patients respectively. They reported 14 patients/month of newly-diagnosed COPD cases. The patients took inhaled glucocorticoids and long-acting b adrenoceptor agonists in separate inhalers. The most frequently-used device was a disc. In opinion of the specialists, half of the therapies initiated recently by GPs for patients with asthma and COPD required modifications.

CONCLUSIONS: There is a disparity between the true state of medical care of asthma and COPD patients and globally-accepted standards.

Get Citation

Keywords

asthma, COPD, health care

About this article
Title

Selected aspects of medical care for patients with asthma and chronic obstructive pulmonary disease (COPD) in Poland

Journal

Advances in Respiratory Medicine

Issue

Vol 85, No 4 (2017)

Pages

179-185

Published online

2017-08-28

DOI

10.5603/ARM.2017.0030

Bibliographic record

Adv Respir Med 2017;85(4):179-185.

Keywords

asthma
COPD
health care

Authors

Joanna Miłkowska-Dymanowska
Adam J. Białas
Paweł Górski

References (20)
  1. Samoliński B, Sybilski AJ, Raciborski F, et al. Prevalence of asthma in children, adolescents and young adults in Poland – results of the ECAP study. Alergia Astma Immunologia. 2009; 14(1): 27–34.
  2. Selroos O, Kupczyk M, Kuna P, et al. National and regional asthma programmes in Europe. Eur Respir Rev. 2015; 24(137): 474–483.
  3. Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008; 63(5): 402–407.
  4. http://ginasthma.org/.
  5. http://goldcopd.org/.
  6. Śliwiński P, Puchalski K. Chronic obstructive pulmonary disease in the awareness of Polish society. Report from the public opinion survey by the Polish Respiratory Society and TNS Polska. Pneumonol Alergol Pol. 2015; 83(1): 1–13.
  7. Kupryś I, Elgalal A, Korzycka-Zaborowska B, et al. Korzycka-Zaborowska B. Underdiagnosis and undertreatment of asthma in general population of Lodz province (Poland), Eur Resp J. 2003; 22: 296s.
  8. Kardas P. Rozpowszechnienie nieprzestrzegania zaleceń terapeutycznych wśród pacjentów leczonych z powodu wybranych schorzeń przewlekłych. Pol Merk Lek. 2011; 184: 215–220.
  9. Panek M, Mokros Ł, Pietras T, et al. The epidemiology of asthma and its comorbidities in Poland--Health problems of patients with severe asthma as evidenced in the Province of Lodz. Respir Med. 2016; 112: 31–38.
  10. Zielinski J, Bednarek M, Górecka D, et al. Increasing COPD awareness. Eur Respir J. 2006; 27(4): 833–852.
  11. Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000; 16(5): 802–807.
  12. Hodder R, Lightstone S. Mój każdy oddech. Poradnik, jak żyć z POChP. Termedia Wydawnictwa Medyczne, Poznań 2010: wydanie II.
  13. Laue J, Melbye H, Halvorsen PA, et al. How do general practitioners implement decision-making regarding COPD patients with exacerbations? An international focus group study. Int J Chron Obstruct Pulmon Dis. 2016; 11: 3109–3119.
  14. Corlateanu A, Covantev S, Mathioudakis A, et al. Ashtma-Chronic obstructive pulmonary disease overlap syndrome (ACOS): current evidence and future research directions. COPD Research and Practice. 2017; 3(1).
  15. Rogala B, Majak P, Glück J, et al. Asthma control in adult patients treated with a combination of inhaled corticosteroids and long‑acting β2‑agonists: a prospective observational study. Pol Arch Intern Med. 2017; 127(2): 100–106.
  16. Barnes PJ. Scientific rationale for using a single inhaler for asthma control. Eur Respir J. 2007; 29(3): 587–595.
  17. Mahler D. Peak inspiratory flow rate as a criterion for dy powder inhaler use in chronic obstructive pulmonary disease. Annals of the American Thoracic Society. 2017.
  18. Moore A, Riddell K, Joshi S, et al. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler. J Aerosol Med Pulm Drug Deliv. 2017; 30(3): 164–172.
  19. Melani AS, Bonavia M, Mastropasqua E, et al. Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri (AIPO). Time Required to Rectify Inhaler Errors Among Experienced Subjects With Faulty Technique. Respir Care. 2017; 62(4): 409–414.
  20. www.gappsurvey.org.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl